Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryonia alba for hospitalized adults with COVID-19
RBR-48fd64kRecruiting
- Sponsor
- Hospital Regional de Mato Grosso do Sul
- Start
- Sep 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial in coronavirus disease 2019 (COVID-19) comparing Bryonia alba plus standard care with Placebo plus standard care (2 arms). Started Sep 2021; status: recruiting.
02
Drugs
bryonia alba
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-48fd64k.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-48fd64k.